Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Blaney

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Blood Cancer Journal|May 31, 2022
Structural variants shape the genomic landscape and clinical outcome of multiple myelomaCody Ashby, Eileen M Boyle, Michael A Bauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2024
Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple MyelomaDickran Kazandjian, Benjamin Diamond, Marios Papadimitriou, et al.
Nature Communications|August 28, 2021
Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myelomaKylee H Maclachlan, Even H Rustad, Andriy Derkach, et al.
Seminars in Cell & Developmental Biology|May 7, 2021
Chromothripsis as a pathogenic driver of multiple myelomaFrancesco Maura, Eileen M Boyle, Even H Rustad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2022
Myeloma Genome Project Panel is a Comprehensive Targeted Genomics Panel for Molecular Profiling of Patients with Multiple MyelomaParvathi Sudha, Aarif Ahsan, Cody Ashby, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2023
Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple MyelomaEileen M Boyle, Patrick Blaney, James H Stoeckle, et al.
Leukemia|June 20, 2021
Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere lengthEileen M Boyle, Louis Williams, Patrick Blaney, et al.
Blood|May 7, 2025
A multiomic analysis of Waldenström macroglobulinemia defines distinct disease subtypesDylan C Gagler, Hussein Ghamlouch, Di Zhang, et al.
Blood|May 10, 2024
The biological and clinical impact of deletions before and after large chromosomal gains in multiple myelomaAnthony M Cirrincione, Alexandra M Poos, Bachisio Ziccheddu, et al.
Blood Cancer Discovery|January 4, 2021
Revealing the impact of structural variants in multiple myelomaEven H Rustad, Venkata D Yellapantula, Dominik Glodzik, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Blood Cancer Journal|May 31, 2022
Structural variants shape the genomic landscape and clinical outcome of multiple myelomaCody Ashby, Eileen M Boyle, Michael A Bauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2024
Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple MyelomaDickran Kazandjian, Benjamin Diamond, Marios Papadimitriou, et al.
Nature Communications|August 28, 2021
Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myelomaKylee H Maclachlan, Even H Rustad, Andriy Derkach, et al.
Seminars in Cell & Developmental Biology|May 7, 2021
Chromothripsis as a pathogenic driver of multiple myelomaFrancesco Maura, Eileen M Boyle, Even H Rustad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2022
Myeloma Genome Project Panel is a Comprehensive Targeted Genomics Panel for Molecular Profiling of Patients with Multiple MyelomaParvathi Sudha, Aarif Ahsan, Cody Ashby, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2023
Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple MyelomaEileen M Boyle, Patrick Blaney, James H Stoeckle, et al.
Leukemia|June 20, 2021
Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere lengthEileen M Boyle, Louis Williams, Patrick Blaney, et al.
Blood|May 7, 2025
A multiomic analysis of Waldenström macroglobulinemia defines distinct disease subtypesDylan C Gagler, Hussein Ghamlouch, Di Zhang, et al.
Blood|May 10, 2024
The biological and clinical impact of deletions before and after large chromosomal gains in multiple myelomaAnthony M Cirrincione, Alexandra M Poos, Bachisio Ziccheddu, et al.
Blood Cancer Discovery|January 4, 2021
Revealing the impact of structural variants in multiple myelomaEven H Rustad, Venkata D Yellapantula, Dominik Glodzik, et al.
Pageof 3